Wellbutrin (bupropion) helps you quit smoking by partially replacing the dopamine boost that nicotine provides, which reduces cravings and eases withdrawal symptoms. In clinical trials, it roughly doubles quit rates compared to placebo. The FDA approved it specifically for smoking cessation in 1997 under the brand name Zyban, making it one of the first non-nicotine prescription options for quitting.
How It Works in Your Brain
Nicotine is addictive largely because it triggers a surge of dopamine, the brain’s reward chemical. When you stop smoking, dopamine levels drop, and you feel irritable, anxious, and intensely craving a cigarette. Bupropion attacks this problem from two directions.
First, it blocks the reabsorption of dopamine and norepinephrine in the brain, keeping more of these chemicals available in the spaces between nerve cells. This mimics some of the rewarding feeling nicotine provides, which is why researchers describe it as an “indirect dopamine agonist.” You’re not getting the same high as a cigarette, but you’re not in a dopamine deficit either. That takes the edge off withdrawal.
Second, bupropion physically blocks certain nicotine receptors in the brain, particularly a type called alpha-3-beta-4 receptors. These receptors normally respond when nicotine arrives and help trigger the release of reward chemicals. By blocking them, bupropion means that even if you do slip and smoke a cigarette, it feels less satisfying than it used to. The usual payoff is blunted, which makes it easier to stay on track.
How Effective It Is
A meta-analysis of clinical trials found that bupropion more than doubles the odds of staying smoke-free at six to twelve months compared to a placebo. In one head-to-head study, quit rates after 10 weeks of treatment were 20% with placebo, 32% with a nicotine patch alone, and 46% with bupropion alone. Combining bupropion with a nicotine patch pushed that number to 51%.
These numbers are realistic, not miraculous. Most people who try to quit will need multiple attempts regardless of method. But bupropion meaningfully shifts the odds in your favor, especially when paired with behavioral support or counseling.
The Treatment Timeline
You start taking bupropion while you’re still smoking. The medication needs about a week to build up to effective levels in your bloodstream, so your prescriber will have you begin the pills and then set a quit date within the first two weeks of treatment. This is different from nicotine replacement, where you typically stop smoking on day one.
The standard course runs 7 to 12 weeks. During the first few days, you’ll usually take one pill daily, then increase to twice daily. The second dose should be taken in the late afternoon, at least eight hours after the morning dose, to avoid sleep problems.
Weight Gain After Quitting
One of the most common concerns about quitting smoking is weight gain, and bupropion offers a modest advantage here. In a placebo-controlled study, people taking bupropion gained an average of 1.7 kilograms (about 3.7 pounds) after quitting, compared to 2.1 kilograms (about 4.6 pounds) for those on placebo. The difference is small but real, and it likely reflects bupropion’s appetite-suppressing effects. For some people, knowing they have this buffer makes the decision to quit less daunting.
Common Side Effects
The most frequently reported side effects are insomnia, dry mouth, nausea, dizziness, and constipation. Most of these are manageable. Taking the medication with food can help with nausea. Drinking plenty of water addresses dry mouth and constipation. Timing that second dose earlier in the afternoon, rather than close to bedtime, usually resolves the sleep issues.
Some people experience nervousness, difficulty concentrating, or mood changes. A rash is less common but worth paying attention to, as it can signal a need to stop the medication.
Seizure Risk and Who Should Avoid It
The most serious risk is seizures, but the actual incidence is low: about 0.1% of patients (1 in 1,000) at the standard 300 mg sustained-release dose used for smoking cessation. Certain conditions raise that risk significantly, which is why bupropion is not appropriate for everyone.
It’s contraindicated if you have a seizure disorder, a current or past diagnosis of anorexia or bulimia (which raised seizure rates in early trials), or if you’re abruptly stopping alcohol, benzodiazepines, or barbiturates. These situations all lower the seizure threshold, and adding bupropion on top creates an unacceptable level of risk.
Combining It With Nicotine Replacement
Because bupropion and nicotine replacement products work through different mechanisms, they can be used together. Bupropion blocks nicotine receptors and boosts dopamine internally, while a patch delivers a low, steady stream of nicotine to further ease physical withdrawal. The clinical data supports this combination: quit rates of 51% with both together versus 46% with bupropion alone and 32% with the patch alone. If one approach on its own hasn’t worked for you in the past, combining the two is a reasonable next step.